Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?

Bernardi S, Voltan R, Rimondi E, Melloni E, Milani D, Cervellati C, Gemmati D, Celeghini C, Secchiero P, Zauli G, Tisato V.

Clin Sci (Lond). 2019 May 16;133(10):1145-1166. doi: 10.1042/CS20181116. Print 2019 May 31. Review.

2.

Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation.

Ziliotto N, Marchetti G, Straudi S, Tisato V, Lavezzi S, Manfredini F, Basaglia N, Bernardi F.

Clin Chim Acta. 2019 May 8;495:374-376. doi: 10.1016/j.cca.2019.05.008. [Epub ahead of print]

PMID:
31077650
3.

Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators.

Gemmati D, Occhionorelli S, Tisato V, Vigliano M, Longo G, Gonelli A, Sibilla MG, Serino ML, Zamboni P.

Sci Rep. 2018 Nov 16;8(1):16916. doi: 10.1038/s41598-018-35185-x.

4.

Plasma levels of soluble NCAM in multiple sclerosis.

Ziliotto N, Zivadinov R, Jakimovski D, Baroni M, Tisato V, Secchiero P, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Bernardi F, Ramanathan M, Marchetti G.

J Neurol Sci. 2019 Jan 15;396:36-41. doi: 10.1016/j.jns.2018.10.023. Epub 2018 Oct 28.

PMID:
30412901
5.

Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Cervellati C, Valacchi G, Tisato V, Zuliani G, Marsillach J.

Minerva Med. 2019 Jun;110(3):238-250. doi: 10.23736/S0026-4806.18.05875-5. Epub 2018 Oct 11. Review.

PMID:
30334443
6.

Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature.

Gallo S, Arcidiacono MV, Tisato V, Piva R, Penolazzi L, Bosi C, Feo CV, Gafà R, Secchiero P.

Onco Targets Ther. 2018 Sep 20;11:6049-6056. doi: 10.2147/OTT.S171678. eCollection 2018.

7.

F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty.

Ansani L, Marchesini J, Pestelli G, Luisi GA, Scillitani G, Longo G, Milani D, Serino ML, Tisato V, Gemmati D.

Int J Mol Sci. 2018 Sep 14;19(9). pii: E2766. doi: 10.3390/ijms19092766.

8.

Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease.

Arcidiacono MV, Rimondi E, Maietti E, Melloni E, Tisato V, Gallo S, Valdivielso JM, Fernández E, Betriu À, Voltan R, Zauli G, Volpato S, Secchiero P.

PLoS One. 2018 Sep 11;13(9):e0203716. doi: 10.1371/journal.pone.0203716. eCollection 2018.

9.

TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress.

Tisato V, Gallo S, Melloni E, Celeghini C, Passaro A, Zauli G, Secchiero P, Bergamini C, Trentini A, Bonaccorsi G, Valacchi G, Zuliani G, Cervellati C.

Mediators Inflamm. 2018 Jul 26;2018:9629537. doi: 10.1155/2018/9629537. eCollection 2018.

10.

Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema.

Tessari M, Tisato V, Rimondi E, Zamboni P, Malagoni AM.

J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):500-510. doi: 10.1016/j.jvsv.2018.01.019.

PMID:
29909855
11.

Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease.

Brombo G, Bonetti F, Ortolani B, Morieri ML, Bosi C, Passaro A, Vigna GB, Borgna C, Arcidicono MV, Tisato V, Zuliani G.

Gerontology. 2018;64(5):414-421. doi: 10.1159/000488318. Epub 2018 May 16.

PMID:
29768278
12.

Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study.

Morano D, Rolfo A, Tisato V, Farina A, Rimondi E, Scutiero G, Greco P, Bonaccorsi G, Todros T.

Pregnancy Hypertens. 2018 Apr;12:1-5. doi: 10.1016/j.preghy.2018.02.002. Epub 2018 Feb 7.

PMID:
29674187
13.

Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.

Tisato V, Zuliani G, Vigliano M, Longo G, Franchini E, Secchiero P, Zauli G, Paraboschi EM, Vikram Singh A, Serino ML, Ortolani B, Zurlo A, Bosi C, Greco A, Seripa D, Asselta R, Gemmati D.

PLoS One. 2018 Mar 8;13(3):e0193867. doi: 10.1371/journal.pone.0193867. eCollection 2018.

14.

TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse.

Bernardi S, Toffoli B, Tisato V, Bossi F, Biffi S, Lorenzon A, Zauli G, Secchiero P, Fabris B.

Clin Sci (Lond). 2018 Jan 5;132(1):69-83. doi: 10.1042/CS20171221. Print 2018 Jan 16.

PMID:
29167318
15.

Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women.

Tisato V, Secchiero P, Bonaccorsi G, Bergamini C, Greco P, Zauli G, Cervellati C.

Mediators Inflamm. 2017;2017:5356020. doi: 10.1155/2017/5356020. Epub 2017 Sep 5.

16.

The calendar of cytokines: Seasonal variation of circulating cytokines in chronic venous insufficiency.

Spath P, Tisato V, Gianesini S, Tessari M, Menegatti E, Manfredini R, Occhionorelli S, Secchiero P, Zamboni P.

JRSM Cardiovasc Dis. 2017 Sep 8;6:2048004017729279. doi: 10.1177/2048004017729279. eCollection 2017 Jan-Dec.

17.

The γ-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells.

Secchiero P, Voltan R, Rimondi E, Melloni E, Athanasakis E, Tisato V, Gallo S, Rigolin GM, Zauli G.

Oncotarget. 2017 Jul 22;8(35):59235-59245. doi: 10.18632/oncotarget.19494. eCollection 2017 Aug 29.

18.

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.

Tisato V, Voltan R, Gonelli A, Secchiero P, Zauli G.

J Hematol Oncol. 2017 Jul 3;10(1):133. doi: 10.1186/s13045-017-0500-5. Review.

19.

Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases.

Zauli G, Tisato V, Raffetto JD, Vaccarezza M.

Mediators Inflamm. 2017;2017:3161968. doi: 10.1155/2017/3161968. Epub 2017 Mar 26. No abstract available.

20.

The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial.

Straudi S, Manfredini F, Lamberti N, Zamboni P, Bernardi F, Marchetti G, Pinton P, Bonora M, Secchiero P, Tisato V, Volpato S, Basaglia N.

Trials. 2017 Feb 27;18(1):88. doi: 10.1186/s13063-017-1838-2.

21.

Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity.

Voltan R, Secchiero P, Casciano F, Milani D, Zauli G, Tisato V.

Int J Biochem Cell Biol. 2016 Dec;81(Pt B):364-374. doi: 10.1016/j.biocel.2016.09.019. Epub 2016 Sep 26. Review.

22.

Oscillatory flow suppression improves inflammation in chronic venous disease.

Zamboni P, Spath P, Tisato V, Tessari M, Dalla Caneva P, Menegatti E, Occhionorelli S, Gianesini S, Secchiero P.

J Surg Res. 2016 Sep;205(1):238-45. doi: 10.1016/j.jss.2016.06.046. Epub 2016 Jun 25.

PMID:
27621026
23.

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.

Gemmati D, Burini F, Talarico A, Fabbri M, Bertocco C, Vigliano M, Moratelli S, Cuneo A, Serino ML, Avato FM, Tisato V, Gaudio RM.

PLoS One. 2016 Sep 8;11(9):e0162084. doi: 10.1371/journal.pone.0162084. eCollection 2016.

24.

Association between circulatory levels of adipokines and bone mineral density in postmenopausal women.

Cervellati C, Bonaccorsi G, Bergamini CM, Fila E, Greco P, Valacchi G, Massari L, Gonelli A, Tisato V.

Menopause. 2016 Sep;23(9):984-92. doi: 10.1097/GME.0000000000000655.

PMID:
27433863
25.

Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment.

Tisato V, Rimondi E, Brombo G, Volpato S, Zurlo A, Zauli G, Secchiero P, Zuliani G.

Dement Geriatr Cogn Disord. 2016;41(5-6):273-80. doi: 10.1159/000446275. Epub 2016 Jun 16.

26.

Clinical perspectives of TRAIL: insights into central nervous system disorders.

Tisato V, Gonelli A, Voltan R, Secchiero P, Zauli G.

Cell Mol Life Sci. 2016 May;73(10):2017-27. doi: 10.1007/s00018-016-2164-7. Epub 2016 Feb 24. Review.

27.

Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity.

Trapella C, Voltan R, Melloni E, Tisato V, Celeghini C, Bianco S, Fantinati A, Salvadori S, Guerrini R, Secchiero P, Zauli G.

J Med Chem. 2016 Jan 14;59(1):147-56. doi: 10.1021/acs.jmedchem.5b01165. Epub 2015 Dec 23.

PMID:
26653539
28.

Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy.

Tisato V, Perri P, Rimondi E, Melloni E, Lamberti G, Milani D, Secchiero P, Zauli G.

Mediators Inflamm. 2015;2015:942948. doi: 10.1155/2015/942948. Epub 2015 Oct 7.

29.

Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus.

Tornese G, Tisato V, Monasta L, Vecchi Brumatti L, Zauli G, Secchiero P.

Acta Diabetol. 2015 Oct;52(5):1003-6. doi: 10.1007/s00592-015-0731-2. Epub 2015 Apr 12. No abstract available.

30.

Intranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine model.

Tisato V, Garrovo C, Biffi S, Petrera F, Voltan R, Casciano F, Meroni G, Agnoletto C, Zauli G, Secchiero P.

PLoS One. 2014 Dec 15;9(12):e115387. doi: 10.1371/journal.pone.0115387. eCollection 2014.

31.

Calcium micro-depositions in jugular truncular venous malformations revealed by Synchrotron-based XRF imaging.

Pascolo L, Gianoncelli A, Rizzardi C, Tisato V, Salomé M, Calligaro C, Salvi F, Paterson D, Zamboni P.

Sci Rep. 2014 Oct 7;4:6540. doi: 10.1038/srep06540.

32.

Ultrastructure of internal jugular vein defective valves.

Zamboni P, Tisato V, Menegatti E, Mascoli F, Gianesini S, Salvi F, Secchiero P.

Phlebology. 2015 Oct;30(9):644-7. doi: 10.1177/0268355514541980. Epub 2014 Jun 27.

33.

In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure.

Voltan R, Zauli G, Rizzo P, Fucili A, Pannella M, Marci R, Tisato V, Ferrari R, Secchiero P.

Mediators Inflamm. 2014;2014:257081. doi: 10.1155/2014/257081. Epub 2014 Mar 23.

34.

Modulation of circulating cytokine-chemokine profile in patients affected by chronic venous insufficiency undergoing surgical hemodynamic correction.

Tisato V, Zauli G, Gianesini S, Menegatti E, Brunelli L, Manfredini R, Zamboni P, Secchiero P.

J Immunol Res. 2014;2014:473765. doi: 10.1155/2014/473765. Epub 2014 Mar 25.

35.

Inhibitory effect of natural anti-inflammatory compounds on cytokines released by chronic venous disease patient-derived endothelial cells.

Tisato V, Zauli G, Rimondi E, Gianesini S, Brunelli L, Menegatti E, Zamboni P, Secchiero P.

Mediators Inflamm. 2013;2013:423407. doi: 10.1155/2013/423407. Epub 2013 Dec 31.

36.

Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells.

Tisato V, Norcio A, Celeghini C, Milani D, Gonelli A, Secchiero P.

Clinics (Sao Paulo). 2014 Jan;69(1):68-74. doi: 10.6061/clinics/2014(01)10.

37.

Inverse correlation between circulating levels of TNF-related apoptosis-inducing ligand and 17β-estradiol.

Zauli G, Tisato V, Melloni E, Volpato S, Cervellati C, Bonaccorsi G, Radillo O, Marci R, Secchiero P.

J Clin Endocrinol Metab. 2014 Apr;99(4):E659-64. doi: 10.1210/jc.2013-4193. Epub 2014 Jan 21.

PMID:
24446659
38.

Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders.

Campioni D, Voltan R, Tisato V, Zauli G.

Front Biosci (Landmark Ed). 2014 Jan 1;19:139-51. Review.

PMID:
24389177
39.

GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients.

Tisato V, Secchiero P, Rimondi E, Gianesini S, Menegatti E, Casciano F, Zamboni P, Zauli G.

Mediators Inflamm. 2013;2013:561689. doi: 10.1155/2013/561689. Epub 2013 Nov 13.

40.

The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement.

Tornese G, Iafusco D, Monasta L, Agnoletto C, Tisato V, Ventura A, Zauli G, Secchiero P.

Acta Diabetol. 2014 Apr;51(2):239-46. doi: 10.1007/s00592-013-0507-5. Epub 2013 Aug 8.

PMID:
23925693
41.

Dose-dependent neuroprotection of VEGF₁₆₅ in Huntington's disease striatum.

Ellison SM, Trabalza A, Tisato V, Pazarentzos E, Lee S, Papadaki V, Goniotaki D, Morgan S, Mirzaei N, Mazarakis ND.

Mol Ther. 2013 Oct;21(10):1862-75. doi: 10.1038/mt.2013.132. Epub 2013 Jun 25.

42.

Endothelial PDGF-BB produced ex vivo correlates with relevant hemodynamic parameters in patients affected by chronic venous disease.

Tisato V, Zamboni P, Menegatti E, Gianesini S, Volpi I, Zauli G, Secchiero P.

Cytokine. 2013 Aug;63(2):92-6. doi: 10.1016/j.cyto.2013.04.018. Epub 2013 May 7.

PMID:
23664275
43.

MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies.

Tisato V, Norcio A, Voltan R, Celeghini C, Zella D, Secchiero P.

Curr Med Chem. 2013;20(17):2226-36. Review.

PMID:
23458617
44.

Oscillatory Turbulent Flow in Chronic Venous Disease Induces Pro-inflammatory and Reparative Biological Signaling.

Gianesini S, Tisato V, Menegatti E, Volpi I, Voltan R, Occhionorelli S, Secchiero P, Zamboni P.

J Vasc Surg Venous Lymphat Disord. 2013 Jan;1(1):108. doi: 10.1016/j.jvsv.2012.10.028. Epub 2012 Dec 8. No abstract available.

PMID:
26993926
45.

Simultaneous determination of multiple cytokines reveals a pro-inflammatory and pro-angiogenic signature after major cardiothoracic surgery: potential role of C-reactive protein.

Tisato V, Monasta L, Biolo G, Donatelli F, Secchiero P, Zauli G.

Cytokine. 2012 Dec;60(3):593-5. doi: 10.1016/j.cyto.2012.08.017. Epub 2012 Sep 13. No abstract available.

PMID:
22981204
46.

State of the art of the therapeutic perspective of sorafenib against hematological malignancies.

Zauli G, Voltan R, Tisato V, Secchiero P.

Curr Med Chem. 2012;19(28):4875-84. Review.

PMID:
22934770
47.

Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells.

Agostinis C, Bulla R, Tisato V, De Seta F, Alberico S, Secchiero P, Zauli G.

Hum Reprod. 2012 Oct;27(10):2941-7. doi: 10.1093/humrep/des289. Epub 2012 Aug 21.

PMID:
22914768
48.

Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB.

Tisato V, Toffoli B, Monasta L, Bernardi S, Candido R, Zauli G, Secchiero P.

Clin Nutr. 2013 Apr;32(2):259-64. doi: 10.1016/j.clnu.2012.07.003. Epub 2012 Jul 26.

PMID:
22840561
49.

Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype.

Tisato V, Zauli G, Voltan R, Gianesini S, di Iasio MG, Volpi I, Fiorentini G, Zamboni P, Secchiero P.

PLoS One. 2012;7(6):e39543. doi: 10.1371/journal.pone.0039543. Epub 2012 Jun 21.

50.

The energy balance positively regulates the levels of circulating TNF-related apoptosis inducing ligand in humans.

Biolo G, Secchiero P, De Giorgi S, Tisato V, Zauli G.

Clin Nutr. 2012 Dec;31(6):1018-21. doi: 10.1016/j.clnu.2012.04.016. Epub 2012 May 24.

PMID:
22633079

Supplemental Content

Loading ...
Support Center